1.
Padmanabhan JL, Nanda P, Tandon N, et al. Polygenic risk for type 2 diabetes mellitus among individuals with psychosis and their relatives. J Psychiatr Res. 2016;77:52-8. doi:10.1016/j.jpsychires.2016.02.015.
1.
Hyman SE. Perspective: Revealing molecular secrets. Nature. 2014;508(7494):S20. doi:10.1038/508S20a.
1.
Leu C, Balestrini S, Maher B, et al. Genome-wide Polygenic Burden of Rare Deleterious Variants in Sudden Unexpected Death in Epilepsy. EBioMedicine. 2015;2(9):1063-70. doi:10.1016/j.ebiom.2015.07.005.
1.
Wang SR, Agarwala V, Flannick J, et al. Simulation of Finnish population history, guided by empirical genetic data, to assess power of rare-variant tests in Finland. Am J Hum Genet. 2014;94(5):710-20. doi:10.1016/j.ajhg.2014.03.019.
1.
Vilhjálmsson BJ, Yang J, Finucane HK, et al. Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores. Am J Hum Genet. 2015;97(4):576-92. doi:10.1016/j.ajhg.2015.09.001.
1.
Rietveld CA, Esko T, Davies G, et al. Common genetic variants associated with cognitive performance identified using the proxy-phenotype method. Proc Natl Acad Sci U S A. 2014;111(38):13790-4. doi:10.1073/pnas.1404623111.
1.
Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511(7510):421-7. doi:10.1038/nature13595.
1.
Groen-Blokhuis MM, Middeldorp CM, Kan K-J, et al. Attention-deficit/hyperactivity disorder polygenic risk scores predict attention problems in a population-based sample of children. J Am Acad Child Adolesc Psychiatry. 2014;53(10):1123-9.e6. doi:10.1016/j.jaac.2014.06.014.
1.
Wright J. Genetics: Unravelling complexity. Nature. 2014;508(7494):S6-7. doi:10.1038/508S6a.